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Abstract
 
P-selectin glycoprotein ligand 1 (PSGL-1) is a sialomucin expressed on leukocytes that medi-
ates neutrophil rolling on the vascular endothelium. Here, the role of PSGL-1 in mediating
lymphocyte migration was studied using mice lacking PSGL-1. In a contact hypersensitivity
model, the infiltration of CD4
 
1
 
 T lymphocytes into the inflamed skin was reduced in PSGL-
1–deficient mice. In vitro–generated T helper (Th)1 cells from PSGL-1–deficient mice did not
bind to P-selectin and migrated less efficiently into the inflamed skin than wild-type Th1 cells.
To assess the role of PSGL-1 in P- or E-selectin–mediated migration of Th1 cells, the cells
were injected into E- or P-selectin–deficient mice. PSGL-1–deficient Th1 cells did not migrate
into the inflamed skin of E-selectin–deficient mice, indicating that PSGL-1 on Th1 cells is the
sole ligand for P-selectin in vivo. In contrast, PSGL-1–deficient Th1 cells migrated into the in-
flamed skin of P-selectin–deficient mice, although less efficiently than wild-type Th1 cells.
This E-selectin–mediated migration of PSGL-1–deficient or wild-type Th1 cells was not al-
tered by injecting a blocking antibody to L-selectin. These data provide evidence that PSGL-1
on Th1 cells functions as one of the E-selectin ligands in vivo.
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Introduction
 
The regulated migration of leukocytes from the blood-
stream into tissues in response to inflammatory stimuli is a
critical component of both innate and adaptive immune re-
sponses. This process involves a variety of adhesion and sig-
naling molecules whose coordinate action defines the selec-
tive migratory behavior of particular classes of leukocytes.
The initial adhesive events in this process, characterized by
the capture of leukocytes followed by their rolling on the
endothelial surface under vascular shear flow, are mediated
by selectins: L-selectin expressed on most leukocytes and
E- and P-selectin expressed on activated endothelium. Pre-
vious studies using blocking antibodies or gene-targeted
mice have demonstrated that all three selectins coordinately
regulate leukocyte trafficking in vivo. Cooperative func-
tioning of P-selectin with either E- or L-selectin is essential
for efficient neutrophil rolling and migration into sites of
inflammation (1–4). In a model of contact hypersensitivity,
a form of delayed-type hypersensitivity induced by cutane-
ous application of a reactive hapten (5), P- and E-selectin
may cooperatively mediate T cell migration into the skin
during the efferent phase (6–8).
All selectins recognize a sialylated and fucosylated glycan
on their counterreceptors. The presentation of the carbo-
hydrate on the protein backbone contributes to the speci-
ficity and affinity of selectin binding. A major question
concerning selectin ligands is whether they mediate physio-
logically relevant cell–cell interaction (9). Multiple studies
have established the physiologic role of P-selectin glyco-
 
protein ligand 1 (PSGL-1) as a predominant ligand for
P-selectin on neutrophils, as is most clearly demonstrated
by the deficient P-selectin–mediated neutrophil rolling in
PSGL-1–deficient mice (10). PSGL-1 on other classes of
leukocytes such as monocytes, T lymphocytes, and mast
cells as well as on hematopoietic stem cells is likely to be a
predominant ligand for P-selectin (11–14), although in
vivo evidence for this remains to be established. Although a
number of reports have shown that PSGL-1 is capable of
binding to E-selectin (15–22) and L-selectin (23–26), no
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direct evidence for the physiologic roles of these interac-
tions has yet emerged. The availability of PSGL-1–defi-
cient mice should help to define the physiological role of
PSGL-1, specifically the role as a ligand for each of the se-
lectins in various cell types.
In this study, we analyzed the role of PSGL-1 in lym-
phocyte trafficking using PSGL-1–deficient mice. We
demonstrate that PSGL-1 plays an important role in Th1
lymphocyte migration into the inflamed skin in an ox-
azolone-induced contact hypersensitivity model. We con-
firm that PSGL-1 on Th1 cells functions as the sole ligand
for P-selectin in vivo. Our data also indicate that PSGL-1
on Th1 cells is an E-selectin ligand in vivo. This is the first
example of a physiologic role for the interaction of PSGL-1
with E-selectin.
 
Materials and Methods
 
Mice.
 
Mice homozygous for the PSGL-1 targeted mutation
(PSGL-1
 
2
 
/
 
2
 
 mice) have been described (10). 8–12-wk-old
PSGL-1
 
2
 
/
 
2
 
 mice and control PSGL-1
 
1
 
/
 
1
 
 mice on the same
mixed genetic background were used. C57BL/6J (B6) mice,
P-selectin–deficient mice on the B6 background, B6 
 
3
 
 129S3/
SvImJ (129S) F2 mice, E-selectin–deficient mice on the B6/129S
background, and P- and E-selectin double-deficient mice on the
B6/129S background were purchased from The Jackson Labora-
tory and used at similar ages. All procedures were approved by
the Animal Care and Use Committee of Beth Israel Deaconess
Medical Center.
 
Selectin–IgG Chimeras.
 
Mouse P- and E-selectin–IgG chime-
ras were constructed from mouse P- and E-selectin cDNAs pro-
vided by Dr. D. Vestweber (University of Münster, Münster,
Germany). Mouse L-selectin–IgG chimera was constructed from
mouse spleen cDNA. The fragments corresponding to their lec-
tin, epidermal growth factor, and two complement repeat do-
mains were amplified by PCR and ligated to CD5 leader–IgG1
vector provided by Dr. B. Seed (Massachusetts General Hospital,
Boston, MA) at NheI and BamHI sites. These selectin–IgG
plasmids were transfected into CHO cells with pSV2neo
(CLONTECH Laboratories, Inc.), and stable transfectants were
selected in the presence of G418 (GIBCO BRL). Selectin–IgG
chimeric proteins were purified from culture supernatants using
protein A–Sepharose (Sigma-Aldrich).
 
Generation of Th1 Cells.
 
Splenic CD4
 
1
 
 T cells were isolated
using Mouse T cell CD4 Subset Column Kit (R&D Systems).
The enriched population was 
 
.
 
95% positive for CD4 staining as
determined by flow cytometry. Purified CD4
 
1
 
 T cells were cul-
tured on 24-well tissue culture plates (Costar) coated with 20 
 
m
 
g/
ml anti-CD3
 
e
 
 (145-2C11; R&D Systems) and 10 
 
m
 
g/ml anti-
CD28 (37.51; BD PharMingen) for 2 d in the presence of 4 ng/
ml IL-2 (R&D Systems), 2 ng/ml IL-12 (R&D Systems), and 4
 
m
 
g/ml anti–IL-4 (11B11; BD PharMingen). The cells were then
transferred to uncoated plates and cultured for an additional 4 d.
 
Cell Adhesion Assays.
 
96-well plates (Flow Laboratories) were
coated with 10 
 
m
 
g/ml selectin–IgG chimeras for 2 h at 37
 
8
 
C and
blocked with 1% BSA in PBS overnight at 4
 
8
 
C. The cells were
labeled with 2
 
9
 
,7
 
9
 
-bis-(2-carboxyethyl)-5-(and-6)-carboxy-fluo-
rescein (BCECF; Molecular Probes), added to each well (5 
 
3 
 
10
 
5
 
per well), and incubated for 20 min at 4
 
8
 
C under rotation (60
rpm). The plates were washed three times with HBSS with CaCl
 
2
 
and MgCl
 
2
 
, and bound cells were quantitated using a Cytofluor
 
2300 (Millipore). In some experiments, the cells were incubated
with 10 
 
m
 
g/ml rabbit anti–PSGL-1 (10), control rabbit IgG
(Sigma-Aldrich), 50 
 
m
 
g/ml anti–L-selectin mAb MEL-14 (BD
PharMingen), or control rat IgG (IgG2a; BD PharMingen) for 30
min on ice and washed.
 
Induction of Contact Hypersensitivity.
 
Mice were sensitized by
the application of 100 
 
m
 
l of 2% (wt/vol) oxazolone (Sigma-Aldrich)
in 4:1 acetone/olive oil (Sigma-Aldrich) on the abdominal skin
on day 0. Some mice were painted with acetone/olive oil alone.
Mice were challenged on day 6 by applying 20 
 
m
 
l of 0.5% (wt/
vol) oxazolone on the left ear (10 
 
m
 
l per side). The right ear was
painted with the vehicle only. Ear swelling responses were mea-
sured using a dial thickness gage (Mitutoyo).
 
Histologic Analyses and Immunohistochemistry.
 
Ear specimens
were taken 24 h after challenge. Histological analyses were per-
formed on formalin-fixed, paraffin-embedded sections stained
with hematoxylin and eosin. For immunohistochemistry, cryostat
sections were fixed in acetone and stained using rat anti-CD4
(Caltag), biotinylated rabbit anti-rat IgG (Vector Laboratories),
and ABC-alkaline phosphatase reagent (Vector Laboratories).
Sections were developed using Vector Red alkaline phosphatase
substrate and counterstained with methylene green.
 
In Vivo Migration Assays.
 
Th1 cells were harvested after 6 d
of culture, and dead cells were removed by centrifugation on
Histopaque 1083 (Sigma-Aldrich). The cells (10
 
7
 
/ml) were radi-
olabeled with 100 
 
m
 
Ci/ml sodium [
 
51
 
Cr]chromate (NEN Life
Science Products) for 1 h at 37
 
8
 
C, washed twice, and resus-
pended in PBS. Cells (2–4 
 
3
 
 10
 
6
 
) were injected into the tail
veins of mice that had been sensitized 7 d before and challenged
on the left ear 24 h before. In some experiments, MEL-14, anti-
E-selectin mAb 9A9 provided by Dr. B. Wolitzky (Coelacanth
Corp., East Windsor, NJ) or its isotype control (200 
 
m
 
g/mouse)
was injected together with the cells. Mice were killed 3 h after
injection, and the radioactivity in the ear was measured using a
Packard gamma scintillation counter.
 
Results and Discussion
 
PSGL-1–deficient Mice Exhibit Reduced CD4
 
1
 
 T Cell In-
filtrate in the Inflamed Skin in a Contact Hypersensitivity
Model.
 
PSGL-1 is highly expressed on T cells and to a
much lower degree on B cells. Flow cytometric analyses of
thymocytes, splenocytes, LN cells, and blood lymphocytes
revealed no alterations in the expression of CD3, CD4,
CD8, TCR-
 
a
 
/
 
b
 
, or B220 in PSGL-1
 
2
 
/
 
2
 
 mice (data not
shown). The normal lymphoid architecture in PSGL-1
 
2
 
/
 
2
 
mice is consistent with the fact that L-selectin is the major
homing receptor for naive lymphocytes (27) and that
PSGL-1 is expressed in a nonfunctional form on naive lym-
phocytes and gains selectin-binding activity during cell acti-
vation (28). Therefore, we studied the role of PSGL-1 in
immune responses after antigen stimulation using an ox-
azolone-induced contact hypersensitivity model. PSGL-1
 
1
 
/
 
1
 
and PSGL-1
 
2
 
/
 
2
 
 mice were sensitized with oxazolone on
the abdominal skin, and 6 d later they were challenged on
the left ear. The kinetics of ear swelling measured over 72 h
after challenge was not significantly different between
PSGL-1
 
1
 
/
 
1
 
 and PSGL-1
 
2
 
/
 
2
 
 mice (data not shown). Histo-
logical analysis of the skin sections from the ears 24 h after
challenge showed characteristic changes of inflammation
including interstitial edema, cellular infiltrate in the dermis 
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Figure 1. Histological analysis of contact hy-
persensitivity response. (A–C) Hematoxylin and
eosin–stained sections from control (A) or chal-
lenged ears (B) and anti-CD4–stained frozen ear
sections from the challenged ears (C) from sen-
sitized PSGL-11/1 (left panel) or PSGL-12/2
mice (right panel). Ear specimens were taken
24 h after challenge. The scale bar indicates 100
mm for A, B top panel, and C; 25 mm for B
bottom panel. (D) The number of infiltrating
cells in the dermis of the control and challenged
ears was quantitated. Data are means 6 SEM
from six mice. (E) The number of infiltrating
CD41 T cells was quantitated on frozen sec-
tions stained with anti-CD4. Data are means 6
SEM from four mice. 
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comprised predominantly of mononuclear cells and neutro-
phils, and microabcesses in the epidermis (Fig. 1 B). These
histologic changes were not observed in unchallenged ear
sections (Fig. 1 A) or challenged ear sections from unsensi-
tized mice. Although the edema in PSGL-1
 
2
 
/
 
2
 
 mice was
similar to that in PSGL-1
 
1
 
/
 
1
 
 mice, the cellular infiltrate in
the dermis was reduced by 60% in PSGL-1
 
2
 
/
 
2
 
 mice (Fig. 1,
B and D). In addition, immunohistochemical analysis
showed that CD4
 
1
 
 T lymphocyte infiltration was reduced
by 72% in PSGL-1
 
2
 
/
 
2
 
 mice (Fig. 1, C and E). These results
suggest that PSGL-1 may play a role in the migration of the
inflammatory cells including CD4
 
1
 
 T lymphocytes into the
inflamed skin in a contact hypersensitivity model.
 
Migration of PSGL-1–deficient Th1 Cells into the Inflamed
Skin Is Impaired.
 
There are two functionally distinct
CD4
 
1
 
 T lymphocyte subsets, Th1 and Th2, characterized
by distinct cytokine production profiles. Previous studies
 
have shown that both P- and E-selectin mediate the migra-
tion of Th1 cells but not Th2 cells to sites of delayed-type
hypersensitivity (8) and that antibodies against PSGL-1 par-
tially inhibit the migration of Th1 cells into these sites (12).
Based on these observations, the migratory behavior of
PSGL-1
 
1
 
/
 
1
 
 and PSGL-1
 
2
 
/
 
2
 
 Th1 cells was studied. PSGL-
1
 
1
 
/
 
1
 
 and PSGL-1
 
2
 
/
 
2
 
 Th1 cells generated in vitro exhibited
indistinguishable profiles of cytokine production and ex-
pression of L-selectin, integrin 
 
a
 
4, and integrin 
 
b
 
2 (data
not shown). These cells were labeled with 
 
51
 
Cr and in-
jected into mice previously sensitized with oxazolone and
challenged on the left ear. The right ear served as control
skin. 3 h after injection, the radioactive cells that accumu-
lated in the ears were measured. Similar to results using
anti–PSGL-1 antibodies (12), the migration of PSGL-1
 
2
 
/
 
2
 
Th1 cells into the inflamed ear of PSGL-1
 
1
 
/
 
1
 
 mice was re-
duced by 66% compared with PSGL-1
 
1
 
/
 
1
 
 Th1 cells, while
the migration into the control ear was comparable between
PSGL-1
 
1
 
/
 
1
 
 and PSGL-1
 
2
 
/
 
2
 
 cells (Fig. 2). No migration
was observed when the cells were injected into mice lack-
ing both P- and E-selectin.
 
PSGL-1–deficient Th1 Cell Binding to P-Selectin but Not to
E-Selectin Is Abolished.
 
PSGL-1 on Th1 cells binds to
P-selectin in vitro (12). The observation that the migration
of PSGL-1
 
2
 
/
 
2
 
 Th1 cells into the inflamed skin is impaired
raises a question whether PSGL-1 on Th1 cells involves
only a P-selectin–mediated process, an E-selectin–mediated
process, or both. To explore this, we tested Th1 cells for
their ability to bind selectins using selectin–IgG chimeras.
No detectable binding was observed for unstimulated
CD4
 
1
 
 cells from PSGL-1
 
1
 
/
 
1
 
 or PSGL-1
 
2
 
/
 
2
 
 mice to either
P-selectin–IgG or E-selectin–IgG (Fig. 3 A). PSGL-1
 
1
 
/
 
1
 
Th1 cells bound P-selectin–IgG and E-selectin–IgG (Fig. 3
A). No binding to L-selectin–IgG by Th1 cells was detect-
able. In contrast to the complete absence of binding of
PSGL-1
 
2
 
/
 
2
 
 Th1 cells to P-selectin, the binding of PSGL-
1
 
2
 
/
 
2
 
 Th1 cells to E-selectin was measurable, albeit reduced
Figure 2. Migration of PSGL-1–deficient Th1 cells into the inflamed
skin is impaired. 51Cr-labeled PSGL-11/1 or PSGL-12/2 Th1 cells were
injected into the tail veins of PSGL-11/1 mice. The mice had been sensi-
tized 6 d before with oxazolone and challenged 24 h before on the left
ear. The mice were killed 3 h after injection, and the radioactivity in the
control and challenged ears was counted. Values are means 6 SEM from
four mice.
Figure 3. Selectin-binding ac-
tivities of PSGL-1–deficient Th1
cells. In vitro–generated Th1
cells from PSGL-11/1 or PSGL-
12/2 mice were labeled with
BCECF and added to 96-well
plates coated with human IgG,
P-selectin–IgG chimera (P-IgG),
or E-selectin–IgG chimera (E-
IgG). The plates were incubated
for 20 min at 48C under rotating
conditions, unbound cells were
removed, and the fluorescence
per well was determined. Per-
cent adhesion equals 100 3
bound cells/total cells added. (A)
Adhesion of PSGL-11/1 or
PSGL-12/2 unstimulated CD41
cells and Th1 cells to selectin–
IgG chimeras. (B) Adhesion of
PSGL-11/1 Th1 cells treated
with anti–PSGL-1 antibodies to selectin–IgG chimeras. PSGL-11/1 Th1 cells were incubated with either rabbit anti–PSGL-1 or nonimmune IgG for 30
min on ice and washed before addition to the wells. Values are means 6 SEM from triplicate wells.1673 Hirata et al. Brief Definitive Report
by 89% compared with PSGL-11/1 cell binding to E-selec-
tin (Fig. 3 A). Similarly, the binding of PSGL-11/1 Th1
cells to E-selectin–IgG was inhibited by 91% by pretreat-
ment of the cells with anti–PSGL-1 antibodies directed
against the NH2-terminal region of PSGL-1 (Fig. 3 B).
Therefore, PSGL-1 plays a role in Th1 cell binding to
E-selectin in vitro. However, PSGL-1 does not appear to
be the sole ligand for E-selectin, as shown by the residual
binding of PSGL-12/2 Th1 cells to E-selectin–IgG. These
in vitro assays demonstrate that PSGL-1 on Th1 cells is the
sole ligand for P-selectin and has a potential role in Th1
cell binding to E-selectin in vivo. The finding that anti–
PSGL-1 antibodies inhibit adhesion of Th1 cells to E-selec-
tin also suggests that the NH2-terminal region of PSGL-1
may be involved in Th1 cell binding to E-selectin.
Migration of PSGL-1–deficient Th1 Cells into the In-
flamed  Skin of E-Selectin–deficient Mice Is Abolished. To test
whether the in vitro observation that PSGL-1 on Th1 cells
is the predominant ligand for P-selectin is relevant during
the in vivo migration of cells into the inflamed skin, PSGL-
11/1 and PSGL-12/2 Th1 cells were injected into the sen-
sitized and challenged E-selectin2/2 mice. This experiment
allows analyses of P-selectin–dependent cell migration in
the absence of E-selectin. The migration of PSGL-11/1 and
PSGL-12/2 Th1 cells into the skin of wild-type B6/129S
control mice was similar to that shown for PSGL-11/1
mice (Fig. 4 A). Ear swelling of E-selectin2/2 mice 24 h af-
ter challenge was comparable to that of B6/129S control
mice. The migration of PSGL-11/1 Th1 cells into the in-
flamed skin of E-selectin2/2 mice was reduced by 37%
compared with that in B6/129S control mice (Fig. 4 A).
The migration of PSGL-12/2 cells into the inflamed skin of
E-selectin2/2 mice was almost abolished. This confirms that
PSGL-1 is the sole ligand for P-selectin on Th1 cells in
vivo and that no other ligands serve as a P-selectin ligand in
the absence of PSGL-1. Previously, we demonstrated that
PSGL-1 is the sole P-selectin ligand during neutrophil roll-
ing (10). Thus, for neutrophil–endothelial cell interaction
and for lymphocyte migration, PSGL-1 is the sole P-selec-
tin ligand. Whether cell adhesion during other P-selectin–
mediated processes is PSGL-1 dependent remains to be de-
termined.
Migration of PSGL-1–deficient Th1 Cells into the Inflamed
Skin of P-Selectin–deficient Mice Is Not Abolished. If PSGL-1
is the sole ligand for P-selectin on Th1 cells in vivo, then
the migration of PSGL-12/2 cells observed when they
were injected into PSGL-11/1 mice must be mediated by
Figure 4. Migration of PSGL-1–deficient Th1 cells into the inflamed
skin of E-selectin– or P-selectin–deficient mice. 51Cr-labeled PSGL-11/1
or PSGL-12/2 Th1 cells were injected into the tail veins of E-selectin2/2
mice and wild-type B6/129S F2 mice (A) or P-selectin2/2 mice and
wild-type B6 mice (B). The mice were killed 3 h after injection, and the
radioactivity in the control and challenged ears was assayed. Values are
means 6 SEM from four mice.
Figure 5. Effect of an anti–L-selectin antibody on Th1 migration in
vivo and adhesion in vitro. (A) 51Cr-labeled PSGL-11/1 or PSGL-12/2
Th1 cells were injected together with anti–L-selectin mAb MEL-14,
anti–E-selectin mAb 9A9, or its isotype control. The mice had been sen-
sitized 6 d before with oxazolone and challenged 24 h before on the left
ear. Values are means 6 SEM from three mice. (B) Adhesion of PSGL-
11/1 or PSGL-12/2 Th1 cells treated with MEL-14 to selectin–IgG chi-
meras. PSGL-11/1 or PSGL-12/2 Th1 cells were incubated with either
MEL-14 or its isotype control for 30 min on ice and washed before addi-
tion to wells. Values are means 6 SEM from triplicate wells.1674 PSGL-1 Is an E-Selectin Ligand in Th1 Cell Migration
E-selectin, as P- and E-selectin together mediate Th1 cell
migration into the inflamed skin (8). This predicts that
PSGL-1 is not required for E-selectin–mediated migration
of Th1 cells. The adhesion assays also suggested the exist-
ence of E-selectin ligands other than PSGL-1 (Fig. 3 A).
To prove this hypothesis, we tested whether PSGL-1 plays
a role in an E-selectin–mediated process by injecting
PSGL-12/2 Th1 cells into P-selectin2/2 mice. This allows
E-selectin–dependent migration to be studied in the ab-
sence of P-selectin. The migration of PSGL-11/1 and
PSGL-12/2 Th1 cells in wild-type B6 controls was similar
to that in PSGL-11/1 mice (Fig. 4 B). The ear swelling re-
sponse in P-selectin2/2 mice measured 24 h after challenge
was comparable to that in B6 controls. In contrast to the
abrogation of migration when injected into E-selectin2/2
mice (Fig. 4 A), the migration of PSGL-12/2 cells into the
inflamed skin of P-selectin2/2 mice was not abolished (Fig.
4 B). These results confirm that PSGL-1 on Th1 cells is not
the sole ligand for E-selectin in vivo. However, compari-
son of the migration of PSGL-11/1 and PSGL-12/2 cells
revealed that PSGL-12/2 cell migration into the inflamed
skin of P-selectin2/2 mice was reduced by 52% compared
with PSGL-11/1 cells (Fig. 4 B). Thus, PSGL-1 plays a role
other than as a P-selectin ligand.
PSGL-1 Is an E-Selectin Ligand in Th1 Cell Migration into
the Inflamed Skin. In view of in vitro results showing that
PSGL-1 binds E-selectin (15–22) and L-selectin (23–26),
we hypothesized that PSGL-1 is serving as an E-selectin
ligand to cooperate with other E-selectin ligands to pro-
mote cell migration, as an L-selectin ligand to mediate leu-
kocyte–leukocyte interaction, or both. Leukocyte–leuko-
cyte interaction mediated by L-selectin–PSGL-1 interaction
has been suggested as a mechanism of amplifying accumula-
tion of leukocytes including lymphocytes on E-selectin un-
der flow (13, 29, 30). To analyze these possibilities, we
compared the migration of PSGL-11/1 and PSGL-12/2
Th1 cells into the inflamed ears of P-selectin2/2 mice in the
presence of anti–L-selectin mAb MEL-14. MEL-14 did not
affect the migration of either PSGL-11/1 or PSGL-12/2
cells into the inflamed skin of P-selectin2/2 mice; anti–
E-selectin mAb 9A9 inhibited the migration of both PSGL-
11/1 and PSGL-12/2 cells (Fig. 5 A). These results suggest
that leukocyte–leukocyte interaction mediated by L-selec-
tin has little effect on the migration of cells and that the less
efficient migration of PSGL-12/2 cells in an E-selectin–
mediated process is due to the lack of PSGL-1–E-selectin
interaction. Indeed, in vitro adhesion assays showed that
MEL-14 did not affect the binding of PSGL-11/1 or
PSGL-12/2 cells to either P-selectin or E-selectin (Fig. 5
B). Thus, the cell accumulation measured in the adhesion
assays reflects the direct binding of cells to the selectins and
leukocyte–leukocyte interaction does not contribute to the
overall cell accumulation. Together, these results indicate
that PSGL-1 on Th1 cells interacts directly with E-selectin
both in vitro and in vivo. This is the first demonstration of
the in vivo role of PSGL-1 as an E-selectin ligand. The mo-
lecular nature of E-selectin ligands other than PSGL-1 on T
cells needs to be determined.
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